AGEN · Agenus Inc · Webcasts, Transcripts & Audio
$6.73
-0.14 (-2.04%)
At close · Nov 13
Return incl. dividend (before tax)
Q2 2025 earnings call transcript
Going-concern doubt
— flagged Nov 5, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because the timing and completion of these transactions are not entirely within our control, in accordance with applicable accounting standards, substantial doubt exists about our ability to continue as a going concern for at least one year after the filing date of this Quarterly Report on Form 10-Q.”View the 10-Q filed Nov 5, 2026
Market Cap
$304.51M
Shares
45.25M
Volume · Nov 13
465.28K
Avg daily vol (3M)
962.63K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Agenus Inc Webcasts
Earnings calls, investor updates, investor days and conferences for Agenus Inc (AGEN), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Conference
Investor event
2026-11-05
Agenus Inc (AGEN) November 5, 2026 Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q3
2026-11-05
Agenus Inc (AGEN) Q3 2026 Earnings Call
Revenue
$31.49M
▲ 4.1% YoY Diluted EPS
$0.02
▼ 99% YoY Gross margin
100.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-10-20
Agenus Inc (AGEN) October 20, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-08-06
Agenus Inc (AGEN) Q2 2026 Earnings Call
Revenue
$34.52M
▲ 34.4% YoY Diluted EPS
$-0.01
Gross margin
100.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-11
Agenus Inc (AGEN) Q1 2026 Earnings Call
Revenue
$33.74M
▲ 40.2% YoY Diluted EPS
$1.02
Gross margin
100.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-31
Agenus Inc (AGEN) Q4 2025 Earnings Call
Revenue
$34.20M*
▲ 27.5% YoY Gross margin
100.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-12-03
Agenus Inc (AGEN) Q3 2025 Earnings Call
Revenue
$30.23M
▲ 20.4% YoY Diluted EPS
$1.94
Gross margin
97.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-27
Agenus Inc (AGEN) Q2 2025 Earnings Call Transcript
Confident tone
BOT/BAL immunotherapy efficacy in colorectal cancer
Regulatory challenges and FDA delays
Phase III trial with CCTG
Revenue
$25.69M
▲ 9.3% YoY Diluted EPS
$-1.00
Gross margin
99.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-12
Agenus Inc (AGEN) Q1 2025 Earnings Call Transcript
Confident tone
FDA and regulatory environment
Colorectal cancer unmet need
BOT/BAL clinical data
Revenue
$24.07M
▼ 14.1% YoY Diluted EPS
$-1.03
Gross margin
99.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-11
Agenus Inc (AGEN) Q4 2024 Earnings Call Transcript
Confident tone
Organ-sparing potential (rectal/colon cancer)
Non-core asset monetization
BOT/BAL clinical activity in colorectal cancer
Revenue
$26.84M*
▼ 68% YoY Gross margin
99.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Agenus Inc (AGEN) Q3 2024 Earnings Call Transcript
Positive tone
BOT/BAL clinical data in MSS colorectal cancer
Upcoming data presentations and pipeline readouts
Cash position and capital constraints
Revenue
$25.11M
▲ 3.3% YoY Diluted EPS
$-3.08
Gross margin
99.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Agenus Inc (AGEN) Q2 2024 Earnings Call Transcript
Confident tone
BOT/BAL in colorectal cancer
FDA regulatory interaction and accelerated filing
Phase II data and upcoming November dataset
Revenue
$23.51M
▼ 7.1% YoY Diluted EPS
$-2.52
Gross margin
99.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
Agenus Inc (AGEN) Q1 2024 Earnings Call Transcript
Positive tone
BOT/BAL lead program in colorectal cancer
Pipeline expansion across other tumors
Regulatory pathway and FDA alignment
Revenue
$28.00M
▲ 22.3% YoY Diluted EPS
$-3.04
Gross margin
99.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-14
Agenus Inc (AGEN) Q4 2023 Earnings Call Transcript
Confident tone
Regulatory pathway and FDA
BOT/BAL program and data
Phase 2 trial readout timing
Revenue
$83.80M*
▲ 195.2% YoY Gross margin
99.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-07
Agenus Inc (AGEN) Q3 2023 Earnings Call Transcript
Revenue
$24.31M
▲ 6.8% YoY Diluted EPS
$-3.29
Gross margin
98.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
Agenus Inc (AGEN) Q1 2023 Earnings Call Transcript
Revenue
$22.90M
▼ 11.7% YoY Diluted EPS
$-4.31
Gross margin
90.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-14
Agenus Inc (AGEN) Q4 2022 Earnings Call Transcript
Revenue
$28.39M*
▲ 40.1% YoY Gross margin
72.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-08
Agenus Inc (AGEN) Q3 2022 Earnings Call Transcript
Revenue
$22.77M
▼ 91% YoY Diluted EPS
$-3.80
▼ 126.9% YoY Gross margin
98.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-09
Agenus Inc (AGEN) Q2 2022 Earnings Call Transcript
Revenue
$20.93M
▲ 95% YoY Diluted EPS
$-3.40
Gross margin
90.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-06-29
Agenus Inc (AGEN) Q1 2022 Earnings Call Transcript
Revenue
$25.94M
▲ 121.4% YoY Diluted EPS
$-3.80
Gross margin
97.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-01
Agenus Inc (AGEN) Q4 2021 Earnings Call Transcript
Revenue
$20.26M*
▼ 35.2% YoY Gross margin
95.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-09
Agenus Inc (AGEN) Q3 2021 Earnings Call Transcript
Revenue
$252.95M
▲ 1605.5% YoY Diluted EPS
$14.13
Gross margin
99.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-09
Agenus Inc (AGEN) Q2 2021 Earnings Call Transcript
Revenue
$10.73M
▼ 60.2% YoY Diluted EPS
$-7.26
Gross margin
93.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-06
Agenus Inc (AGEN) Q1 2021 Earnings Call Transcript
Revenue
$11.72M
▼ 22.5% YoY Gross margin
90.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-03-15
Agenus Inc (AGEN) Q4 2020 Earnings Call Transcript
Revenue
$31.27M
▼ 9.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-16
Agenus Inc (AGEN) Q3 2020 Earnings Call Transcript
Revenue
$14.83M
▼ 25.6% YoY Diluted EPS
$-5.50
Gross margin
93.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-06
Agenus Inc (AGEN) Q2 2020 Earnings Call Transcript
Revenue
$26.95M
▲ 71.5% YoY Gross margin
97.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-07
Agenus Inc (AGEN) Q1 2020 Earnings Call Transcript
Revenue
$15.13M
▼ 81.1% YoY Diluted EPS
$-6.08
▼ 358.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-03-12
Agenus Inc (AGEN) Q4 2019 Earnings Call
Revenue
$34.50M
▲ 434.8% YoY Diluted EPS
$-4.32
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–29 of 29 webcasts
Key facts
CIK
1098972
CUSIP
00847G804
13F (30d)
95 filings
82 filers
Visit website
Investor relations